XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Note 10 - Stockholders' Equity
6 Months Ended
Aug. 31, 2020
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
NOTE
10
– STOCKHOLDERS' EQUITY
 
Cash Dividend
 
The Company paid a quarterly cash dividend of
$0.12
per common share on
March 15, 2019
to stockholders of record on
March 5, 2019.
The Company paid a quarterly cash dividend of
$0.12
per share of common stock on
June 14, 2019
to stockholders of record on
June 4, 2019.
The Company paid a quarterly cash dividend of
$0.12
per share of common stock on
September 13, 2019
to stockholders of record on
September 4, 2019.
The Company paid a quarterly cash dividend of
$0.12
per share of common stock on
December 6, 2019
to stockholders of record on
November 22, 2019.
The Company paid a quarterly cash dividend of
$0.12
per share of common stock on
March 13, 2020
to stockholders of record on
February 28, 2020.
 
Future declarations of dividends will depend on, among other things, the Company's results of operations, financial condition, capital requirements, and on such other factors as the Company's Board of Directors
may
in its discretion consider relevant and in the best long-term interest of the Company's stockholders.
 
As previously announced in
May 2020,
the Board of Directors suspended the Company's
first
quarter cash dividend payment to preserve cash and provide additional flexibility in the current environment as a result of the economic impact of COVID-
19.
Furthermore, the Board of Directors has suspended future quarterly dividends until the significant uncertainty of the current public health crisis and global economic climate has passed, and the Board of Directors determines that resumption of dividend payments is in the best interest of the Company and its stockholders.
 
Stock Repurchases
 
On
July 15, 2014,
the Company publicly announced a plan to repurchase up to
$3.0
million of its common stock in the open market or in private transactions, whenever deemed appropriate by management. On
January 13, 2015,
the Company announced a plan to purchase up to an additional
$2,058,000
of its common stock under the repurchase plan, and on
May 21, 2015,
the Company announced a further increase to the repurchase plan by authorizing the purchase of up to an additional
$2,090,000
of its common stock under the repurchase plan. The Company did
not
repurchase any shares during the
three
and
six
months ended
August 31, 2020.
As of
August 31, 2020,
approximately
$638,000
remains available under the repurchase plan for further stock repurchases.
 
Warrants
 
In consideration of Edible entering into the exclusive supplier agreement and the performance of its obligations therein, on
December 20, 2019,
the Company issued Edible a warrant (the “Warrant”) to purchase up to
960,677
shares of the Company's common stock (the “Warrant Shares”) at an exercise price of
$8.76
per share. The Warrant Shares vest in annual tranches in varying amounts following each contract year under the exclusive supplier agreement, subject to, and only upon, Edible's achievement of certain revenue thresholds on an annual or cumulative
five
-year basis in connection with its performance under the exclusive supplier agreement. The Warrant expires
six
months after the final and conclusive determination of revenue thresholds for the
fifth
contract year and the cumulative revenue determination in accordance with the terms of the Warrant.
 
The Company determined that the grant date fair value of the warrants was de minimis and did
not
record any amount in consideration of the warrants. The Company utilized a Monte Carlo model for purposes of determining the grant date fair value.
 
Stock-Based Compensation
 
Under the Company's
2007
Equity Incentive Plan (as amended and restated) (the
“2007
Plan”), the Company
may
authorize and grant stock awards to employees, non-employee directors and certain other eligible participants, including stock options, restricted stock and restricted stock units. On
September 17, 2020,
the Company's stockholders approved an amendment and restatement of the
2007
Plan to (
1
) increase the number of authorized shares under the
2007
Plan by
300,000
shares and (
2
) to extend the term of the
2007
Plan to
September 17, 2030.
As of the filing date of this report, there were
319,324
shares available for issuance as awards under the
2007
Plan.
 
ROCKY MOUNTAIN CHOCOLATE FACTORY, INC. AND SUBSIDIARIES
NOTES TO INTERIM (UNAUDITED) CONSOLIDATED FINANCIAL STATEMENTS
 
The Company recognized
$143,719
and
$287,437
of stock-based compensation expense during the
three
- and
six
-month periods ended
August 31, 2020,
respectively, compared to
$155,416
and
$386,670
during the
three
- and
six
-month periods ended
August 31, 2019,
respectively. Compensation costs related to stock-based compensation are generally amortized over the vesting period of the stock awards.
 
The following table summarizes restricted stock unit activity during the
six
months ended
August 31, 2020
and
2019:
 
   
Six Months Ended
 
   
August 31,
 
   
2020
   
2019
 
Outstanding non-vested restricted stock units as of February 28 or 29:
   
265,555
     
25,002
 
Granted
   
-
     
270,000
 
Vested
   
(47,929
)    
(28,502
)
Cancelled/forfeited
   
-
     
-
 
Outstanding non-vested restricted stock units as of August 31:
   
217,626
     
266,500
 
                 
Weighted average grant date fair value
  $
9.40
    $
9.40
 
Weighted average remaining vesting period (in years)
   
4.15
     
5.14
 
 
The Company did
not
issue any unrestricted shares of stock to non-employee directors during the
six
months ended
August 31, 2020
compared to an aggregate of
4,833
shares issued during the
six
months ended
August 31, 2019.
In connection with these non-employee director stock issuances, the Company recognized
$0
and
$45,652
of stock-based compensation expense during the
six
months ended
August 31, 2020
and
2019,
respectively.
 
During the
three
- and
six
-month periods ended
August 31, 2020,
the Company recognized
$143,719
and
$287,437,
respectively, of stock-based compensation expense related to restricted stock unit grants. The restricted stock unit grants generally vest in equal annual or quarterly installments over a period of
five
to
six
years. During the
six
-month periods ended
August 31, 2020
and
2019,
47,929
and
28,502
restricted stock units vested and were issued as common stock, respectively. Total unrecognized compensation expense of non-vested, non-forfeited restricted stock units granted as of
August 31, 2020
was
$1,850,943,
which is expected to be recognized over the weighted-average period of
4.15
years.
 
The Company has
no
outstanding stock options as of
August 31, 2020.